Guru Ownership Trend
Guru Analysis for Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.28 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $10,625 net inflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 72.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Olema Pharmaceuticals, Inc. (OLMA)
Major holders include Steven Cohen ($7.7 M), Cliff Asness ($2.03 M), Renaissance Technologies (RenTech) ($626,675). According to the latest reported data, 4 tracked investment managers collectively hold approximately 417,124 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $10,625, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited OLMA. The total reported sell value was $1.63 M.
Yes, 1 managers opened new positions in OLMA, and 1 increased their existing holdings. The total reported buy value was $1.64 M.